comparemela.com
Home
Live Updates
Patient Toxicity and QOL Concerns Must Be Considered in Brea
Patient Toxicity and QOL Concerns Must Be Considered in Brea
Patient Toxicity and QOL Concerns Must Be Considered in Breast Cancer Treatment Decision-Making
Jane L. Meisel, MD, discusses the importance of prioritizing patients’ toxicity concerns and quality of life in the management of breast cancer.
Related Keywords
Georgia ,
United States ,
Atlanta ,
Emory University School Of Medicine ,
San Antonio ,
Texas ,
Janel Meisel ,
,
Facebook ,
Department Of Gynecology ,
Twitter ,
Quality Of Life ,
Department Of Hematology ,
Life Survey ,
Antonio Breast Cancer Symposium ,
Medical Oncology ,
Emory University School ,
D ,
Estrogen Receptor Positive Her2 Negative ,
Breast Cancer ,
Treatment Related Adverse Effects ,
Trae ,
Healthcare Providers ,
Tolerability Concerns ,
Shared Decision Making ,
Esr1 Quality Of Life Survey 3 ,
Rqol ,
Sabcs ,
2023 San Antonio Breast Cancer Symposium ,